INS and Alzheimer disease: Intranasal insulin has revealed no effects on full-length APP expression neither Aß dodecamers in the frontal cortex or hippocampus, but it decreases Aß oligomers in the hippocampus [248] and Aß40 in the forebrain of 3xTg-AD mice [249].